Literature DB >> 10444806

Nephrotic syndrome and acute interstitial nephritis associated with the use of diclofenac.

T Révai1, G Harmos.   

Abstract

Commonly reported renal complications of non-steroidal anti-inflammatory drugs (NSAID) include acute renal failure and/or acute interstitial nephritis; in rare cases a nephrotic syndrome was also observed. In most cases this was due to the development of secondary membranous nephropathy. Following withdrawal of the drug the nephrotic syndrome usually resolved rapidly. We report a 65-year-old woman who developed a nephrotic syndrome and acute renal failure during 6 months of treatment with the NSAID diclofenac. Renal biopsy revealed both, membranous nephropathy and interstitial nephritis. After discontinuation of diclofenac and treatment with prednisone 1 mg/kg/day, furosemide 400 mg/day and simvastatin at a dose of 20 mg/day, creatinine clearance gradually increased and after 5 months of treatment complete remission of the nephrotic syndrome was observed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10444806

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  3 in total

1.  Successful relatively low-dose corticosteroid therapy for diclofenac-induced acute interstitial nephritis with severe renal failure.

Authors:  Makoto Inoue; Tetsu Akimoto; Osamu Saito; Yasuhiro Ando; Shigeaki Muto; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2008-02-15       Impact factor: 2.801

2.  Effects of subchronic exposure of diclofenac on growth, histopathological changes, and oxidative stress in zebrafish (Danio rerio).

Authors:  Eva Praskova; Lucie Plhalova; Lucie Chromcova; Stanislava Stepanova; Iveta Bedanova; Jana Blahova; Martin Hostovsky; Misa Skoric; Petr Maršálek; Eva Voslarova; Zdenka Svobodova
Journal:  ScientificWorldJournal       Date:  2014-02-05

3.  A case of severe nephrotoxicity associated with long-term dietary supplement use.

Authors:  Farrukh M Koraishy; Gilbert W Moeckel; David S Geller
Journal:  Clin Nephrol       Date:  2017-08-02       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.